BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 19416257)

  • 61. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
    Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
    Calzavara-Pinton P; Zane C; Pacou M; Szeimies RM
    Eur J Dermatol; 2016 Oct; 26(5):487-492. PubMed ID: 27352420
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MAL Daylight Photodynamic Therapy for Actinic Keratosis: Clinical and Imaging Evaluation by 3D Camera.
    Cantisani C; Paolino G; Pellacani G; Didona D; Scarno M; Faina V; Gobello T; Calvieri S
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409613
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
    Fargnoli MC; Ibbotson SH; Hunger RE; Rostain G; Gaastra MTW; Eibenschutz L; Cantisani C; Venema AW; Medina S; Kerrouche N; Pérez-Garcia B
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):757-762. PubMed ID: 29136306
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is the thin layer of methyl aminolevulinate used during photodynamic therapy sufficient?
    Wiegell SR; Lerche CM; Wulf HC
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):88-92. PubMed ID: 26577455
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial.
    Torezan L; Grinblat B; Haedersdal M; Festa-Neto C; Szeimies RM
    Eur J Dermatol; 2021 Oct; 31(5):638-644. PubMed ID: 34789450
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
    Lee PK; Kloser A
    J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of Expedited Microneedle-Assisted Photodynamic Therapy for Field Treatment of Actinic Keratoses: A Randomized Clinical Trial.
    Petukhova TA; Hassoun LA; Foolad N; Barath M; Sivamani RK
    JAMA Dermatol; 2017 Jul; 153(7):637-643. PubMed ID: 28514458
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
    Fonda-Pascual P; Alegre-Sánchez A; Harto-Castaño A; Moreno-Arrones OM; Pérez-García B; González-Morales ML; Pindado-Ortega C; Gilaberte-Calzada Y; Aguilera J; Jaen-Olasolo P; Fernández-Guarino M
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():136-141. PubMed ID: 30508663
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
    Dragieva G; Prinz BM; Hafner J; Dummer R; Burg G; Binswanger U; Kempf W
    Br J Dermatol; 2004 Jul; 151(1):196-200. PubMed ID: 15270891
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
    Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
    Heerfordt IM; Bieliauskiene G; Wulf HC
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: A case series.
    Galimberti GN
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():172-175. PubMed ID: 29203353
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of occlusive vs non-occlusive application of methyl aminolevulinate on the efficacy and tolerability of daylight photodynamic therapy for actinic keratosis.
    Trave I; Salvi I; Serazzi FA; Schiavetti I; Luca L; Parodi A; Cozzani E
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104049. PubMed ID: 38490345
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
    Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
    Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
    Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
    Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp.
    Tarstedt M; Rosdahl I; Berne B; Svanberg K; Wennberg AM
    Acta Derm Venereol; 2005; 85(5):424-8. PubMed ID: 16159735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.